Related Experiment Videos
[Electrophysiologic study of fenoxedil chlorhydrate]
Acta Cardiologica
|January 1, 1976
Summary
Fenoxedil Chlorhydrate, a novel anti-arrhythmic medication, consistently alters intra-nodal cardiac conduction and increases refractory periods. These findings enhance understanding of its anti-arrhythmic mechanisms for clinical application.
Area of Science:
- Cardiology
- Pharmacology
- Electrophysiology
Background:
- Cardiac arrhythmias pose significant clinical challenges.
- Developing novel anti-arrhythmic drugs is crucial for effective patient management.
Purpose of the Study:
- To investigate the electrophysiologic effects of Fenoxedil Chlorhydrate.
- To elucidate the cardiac conduction mechanisms of this new anti-arrhythmic agent.
Main Methods:
- Electrophysiologic studies were conducted on 10 patients.
- Measurements were taken before and during Fenoxedil Chlorhydrate therapy.
Main Results:
- Fenoxedil Chlorhydrate demonstrated a consistent alteration of intra-nodal conduction.
- Increased auricular and ventricular refractory periods were observed in most patients.
- Modifications in sinus node function were less pronounced.
Conclusions:
- Fenoxedil Chlorhydrate exerts specific effects on cardiac electrophysiology, particularly intra-nodal conduction.
- Understanding these mechanisms aids in the clinical prescription of Fenoxedil Chlorhydrate.
- The drug shows potential as an anti-arrhythmic therapy.